The Computational/Bioinformatics Core will be integral to all four of the projects in the Program Project but will be of particular importance to Projects 1 and 2. For Project 1, tools for assembly of contigs, identification and automated and manual annotation of genes, and databases for the storage of assemblies, genes, annotations, sequences, primers for cloning and for tracking of the cloning process are all already in place. Most applications make use of existing tools (BLAST, CAP3, Apollo viewer, Gbrowse) linked with Perl scripts to automate the processes. Future efforts will include integrating the fully assembled and annotated T. cruzi genome into the workflow. In addition, tools will be added to track the results of vaccination trials on a gene-by-gene basis. Project 2 uses commercial software (Matrix Mascot) for matching mass spectra to our ORF databases but requires significant scripting for the automation of pre- and post-Mascot analysis. In addition, tools to extract the maximum amount of information from the ms/ms data are in development, including de novo sequencing tools. The results of vaccine trials in Project 3 will be added to our database of genes as each gene is examined individually or in pools and a patient database will be used to track the results from Project 4. Maintenance of this infrastructure and the addition of new tools will be the job of this core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI044979-08
Application #
7193455
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
8
Fiscal Year
2006
Total Cost
$227,501
Indirect Cost
Name
University of Georgia
Department
Type
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Castro Eiro, Melisa D; Alvarez, María G; Cooley, Gretchen et al. (2017) The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects. Front Immunol 8:1141
Weatherly, D Brent; Peng, Duo; Tarleton, Rick L (2016) Recombination-driven generation of the largest pathogen repository of antigen variants in the protozoan Trypanosoma cruzi. BMC Genomics 17:729
Alvarez, María G; Bertocchi, Graciela L; Cooley, Gretchen et al. (2016) Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses. PLoS Negl Trop Dis 10:e0004657
Albareda, M Cecilia; Perez-Mazliah, Damián; Natale, M Ailén et al. (2015) Perturbed T cell IL-7 receptor signaling in chronic Chagas disease. J Immunol 194:3883-9
Bustamante, Juan M; Tarleton, Rick L (2014) Potential new clinical therapies for Chagas disease. Expert Rev Clin Pharmacol 7:317-25
Hartley, Ashley N; Cooley, Gretchen; Gwyn, Sarah et al. (2014) Frequency of IFN?-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection. Vet Res 45:6
Bustamante, Juan M; Craft, Julie M; Crowe, Byron D et al. (2014) New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice. J Infect Dis 209:150-62
Perez-Mazliah, D E; Alvarez, M G; Cooley, G et al. (2013) Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. J Antimicrob Chemother 68:424-37
Argüello, Rafael J; Albareda, María C; Alvarez, María G et al. (2012) Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease. PLoS One 7:e35966
Minning, Todd A; Weatherly, D Brent; Flibotte, Stephane et al. (2011) Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization. BMC Genomics 12:139

Showing the most recent 10 out of 32 publications